Blog
RSS FeedPosted by Michael Wonder on 26 Apr 2017
Orexigen Therapeutics announces new drug submission for Contrave in Canada
25 April 2017 - Orexigen Therapeutics today announced that Health Canada has completed its screening phase and accepted for review ...
Posted by Michael Wonder on 16 Mar 2017
Cardiome receives Notice of Compliance from Health Canada for its Brinavess NDS
14 March 2017 - Cardiome Pharma Corporation announced today that it received a Notice of Compliance for Brinavess (vernakalant hydrochloride, IV) ...
Posted by Michael Wonder on 05 Mar 2017
Acerus files a new drug submission for Gynoflor in Canada
1 March 2017 - Acerus Pharmaceuticals today announced that it has filed a new drug submission for Gynoflor with Health Canada. ...
Posted by Michael Wonder on 29 Jun 2016
Sandoz Canada regulatory submission for subsequent entry biologic etanercept accepted for review by Health Canada
28 June 2016 - Sandoz Canada announced today that Health Canada has accepted for review its regulatory submission for a ...
Posted by Michael Wonder on 22 Mar 2016
Raptor's Procysbi new drug submission accepted by Health Canada with priority review
21 March 2016 - Raptor Pharmaceutical Corporation today announced that Health Canada has accepted for review its New Drug Submission for ...